Influenza

Latest News

Invasive Aspergillosis Superinfection Possible in Symptomatic COVID-19

By

Zahra Masoud

Critically ill patients hospitalized with COVID-19 — particularly those who develop ARDS — may also experience an opportunistic aspergillosis superinfection.

Reduced Hospitalization Among People With Diabetes With Multi-Season Influenza Vaccination

By

Zahra Masoud

Influenza hospitalizations were decreased among people with diabetes when vaccines were received in multiple influenza seasons.

Influenza Vaccination Not Associated With Major Congenital Malformations

By

Zahra Masoud

Study reveals no evidence for an association between first-trimester vaccination and major malformations or congenital heart defects in infants.

Proper Technique Needed to Avoid Influenza Vaccination-Induced Bursitis

By

Bradley van Paridon

A team of investigators conducted a retrospective cohort study to determine the risk of subdeltoid bursitis associated with the administration of the influenza vaccine.

Reactogenicity of Enhanced Influenza Vaccines in Older Adults

By

Bradley van Paridon

A team of investigators report on the findings from a randomized controlled trial of 3 enhanced influenza vaccines and a standard-dose vaccine in older adults.

Monitoring for Trends in COVID-19 Needed

By

Zahra Masoud

In response to the COVID-19 pandemic, New York State implemented a series of community mitigation strategies, and monitoring approaches are needed to assess the effect of these interventions.

Cell-Cultured Superior to Egg-Derived Influenza Vaccine

By

Zahra Masoud

Cell-cultured quadrivalent influenza vaccines may have greater effectiveness compared with standard, egg-derived quadrivalent influenza vaccines.

Influenza Vaccine Not Linked to Decrease in Hospitalizations or Mortality Among Elderly

By

Zahra Masoud

Targeting the elderly (individuals aged 65 years) for influenza vaccination may not decrease hospitalization or mortality rates in this population.

Poorer Clinical Outcomes in COVID-19 Driven by Comorbidities

By

Virginia A. Schad, PharmD, RPh

In laboratory-confirmed cases of COVID-19, patients with any comorbidities have experienced poorer clinical outcomes compared with those without comorbidities.

COVID-19 vs H1N1 Influenza: A Clinical Characteristic Comparison

By

Bryant Moeller

Hospitalized patients withCOVID-19 had higher proportions of nonproductive cough, fatigue, and gastrointestinal symptoms as well as lower severity of illness scores compared with patients with H1N1 influenza.

Contribution of Leaky Vaccine Effect to Influenza Effectiveness

By

Bradley van Paridon

The observed intra-seasonal decreases of measured influenza vaccine effectiveness was only partially accounted for by leaky vaccine bias.

Face Masks Offer Slight Protective Effect From Flu-Like Illness

Wearing face masks could be slightly protective against primary infection with influenza-like illness from casual community contact.

Frequency and Factors Associated With Hospital Readmissions Due to Influenza

By

Sweta Gupta

Hospitalization due to influenza leads to a high likelihood of readmission within 30 days and 1 year with cardiovascular, respiratory, and infectious etiologies being the most common.

Universal FLU-v Influenza Vaccine, Immunogenic and Warrants Further Testing

By

Bradley van Paridon

The adjuvanted, broad-spectrum influenza vaccine FLU-v was found to be immunogenic and merits phase 3 development to explore efficacy.

Does Seasonal Influenza Vaccine Increase Risk for Guillain-Barré Syndrome?

By

Brandon May

Researchers determined the risk for Guillain-Barré Syndrome following seasonal influenza vaccination in a real-world study.

FDA to Review Baloxavir for Pediatric Use, Postexposure Prophylaxis of Influenza

By

Diana Ernst, RPh

Baloxavir inhibits the endonuclease activity of the polymerase acidic protein resulting in inhibition of influenza virus replication.

Addressing Parents’ Concerns Improves Influenza Immunization Rates

By

Madeline Morr

Implementation of an influenza immunization program increased vaccinations rates from 44% to 57% the following year.

Neuraminidase Inhibitor Treatment for Influenza B-Related Pneumonia

By

Zahra Masoud

Early neuraminidase inhibitor therapy may result in better outcomes in patients hospitalized with influenza B-related pneumonia.

Fluad Quadrivalent Influenza Vaccine Approved for Older Adults

By

Diana Ernst, RPh

The FDA has approved Fluad Quadrivalent for active immunization in patients 65 years of age and older against influenza disease caused by influenza virus subtypes A and types B contained in the vaccine.

Oseltamivir Not Linked to Increase Risk for Neuropsychiatric Events

By

Infectious Disease Advisor Contributing Writer

No difference was seen in the risk for serious neuropsychiatric events in patients who received oseltamivir in the 30 days after influenza diagnosis compared with those who did not.